The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis

Gut

Volumn 65, Issue 6, 2016, Pages 977-989

  Ling, Hui ^a   Pickard, Karen ^b   Ivan, Cristina ^a   Isella, Claudio ^c,d   Ikuo, Mariko ^a,e   Mitter, Richard ^f   Spizzo, Riccardo ^g   Bullock, Marc D ^a,b   Braicu, Cornelia ^h   Pileczki, Valentina ^h   Vincent, Kimberly ^a   Pichler, Martin ^a,i   Stiegelbauer, Verena ⁱ   Hoefler, Gerald ⁱ   Almeida, Maria I ^a,j   Hsiao, Annie ^a   Zhang, Xinna ^a   Primrose, John N ^b   Packham, Graham K ^b   Liu, Kevin ^a   Bojja, Krishna ^a   Gafà, Roberta ^k   Xiao, Lianchun ^a   Rossi, Simona ^a   Song, Jian H ^a   Vannini, Ivan ^l   Fanini, Francesca ^l   Kopetz, Scott ^a   Zweidler McKay, Patrick ^a   Wang, Xuemei ^a   Ionescu, Calin ^m,n   Irimie, Alexandru ⁿ   Fabbri, Muller ^l,o   Lanza, Giovanni ^k   Hamilton, Stanley R ^a   Berindan Neagoe, Ioana ^h,n   Medico, Enzo ^c,d   Mirnezami, Alex H ^b   Calin, George A ^a   Nicoloso, Milena S ^a,g   more..

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF TURIN   (Italy)

^d CANDIOLO CANCER INSTITUTE   (Italy)

^e UNIVERSITY OF TOKYO   (Japan)

^f IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^g CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^h THE ONCOLOGY INSTITUTE PROF DR ION CHIRICUTA   (Romania)

ⁱ MEDICAL UNIVERSITY OF GRAZ   (Austria)

^j INEB INSTITUTO DE ENGENHARIA BIOMÉDICA   (Portugal)

^k UNIVERSITY OF FERRARA   (Italy)

^l DEPARTMENT OF MEDICAL ONCOLOGY   (Italy)

^m The 1st Laboratory of Genetic Explorations   (Romania)

ⁿ IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^o UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 141; MICRORNA 181B; MICRORNA 191; MICRORNA 200A; MICRORNA 200B; MICRORNA 203; MICRORNA 215; MICRORNA 221; MICRORNA 222; MICRORNA 224; MICRORNA 425; SMAD4 PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN; TUMOR MARKER;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CENTER; CANCER STAGING; CANCER SURVIVAL; CELL MOTILITY; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE TARGETING; HCT116 CELL LINE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LUCIFERASE ASSAY; MAJOR CLINICAL STUDY; MALE; METASTASIS FREE SURVIVAL; METASTATIC COLORECTAL CANCER; MICROARRAY ANALYSIS; MICROSATELLITE INSTABILITY; MOUSE; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR VOLUME; UPREGULATION; WESTERN BLOTTING; ADENOCARCINOMA; ANIMAL; AUSTRIA; BLOOD; CLINICAL TRIAL; COLORECTAL NEOPLASMS; GENE EXPRESSION REGULATION; GENETICS; ITALY; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PATHOLOGY; PREDICTIVE VALUE; ROMANIA; SECONDARY; SENSITIVITY AND SPECIFICITY; TUMOR INVASION; UNITED KINGDOM; VERY ELDERLY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; AUSTRIA; BIOMARKERS, TUMOR; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IN VITRO TECHNIQUES; ITALY; KAPLAN-MEIER ESTIMATE; MALE; MICE; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; PREDICTIVE VALUE OF TESTS; ROMANIA; SENSITIVITY AND SPECIFICITY; UNITED KINGDOM;

EID: 84929589715     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2015-309372     Document Type: Article

References (33)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013;63:11-30.
2. Markowitz SD, Bertagnolli MM. Molecular origins of cancer: Molecular basis of colorectal cancer. N Engl J Med 2009;361:2449-60.
3. Lindmark G, Gerdin B, Pahlman L, et al. Prognostic predictors in colorectal cancer. Dis Colon Rectum 1994;37:1219-27.
4. He L, Hannon GJ. MicroRNAs: Small RNAs with a big role in gene regulation. Nat Rev Genet 2004;5:522-31.
5. Slaby O, Svoboda M, Michalek J, et al. MicroRNAs in colorectal cancer: translation of molecular biology into clinical application. Mol Cancer 2009;8:102.
6. Bandres E, Cubedo E, Agirre X, et al. Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer 2006;5:29.
7. Ma Y, Zhang P, Yang J, et al. Candidate microRNA biomarkers in human colorectal cancer: systematic review profiling studies and experimental validation. Int J Cancer 2012;130:2077-87.
8. Brabletz T, Hlubek F, Spaderna S, et al. Invasion and metastasis in colorectal cancer: epithelial-mesenchymal transition, mesenchymal-epithelial transition, stem cells and beta-catenin. Cells Tissues Organs 2005;179:56-65.
9. Boland CR, Thibodeau SN, Hamilton SR, et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998;58:5248-57.
10. Liu CG, Calin GA, Meloon B, et al. An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Proc Natl Acad Sci USA 2004;101:9740-4.
11. Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012;487:330-7.
12. Popat S, Hubner R, Houlston RS. Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol 2005;23:609-18.
13. Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science 1993;260:816-19.
14. Cimmino A, Calin GA, Fabbri M, et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 2005;102:13944-9.
15. Adamopoulos PG, Kontos CK, Rapti SM, et al. miR-224 overexpression is a strong and independent prognosticator of short-term relapse and poor overall survival in colorectal adenocarcinoma. Int J Oncol 2015;46:849-59.
16. Ke TW, Hsu HL, Wu YH, et al. MicroRNA-224 suppresses colorectal cancer cell migration by targeting Cdc42. Dis Markers 2014;2014:617150.
17. Wang Y, Ren J, Gao Y, et al. MicroRNA-224 targets SMAD family member 4 to promote cell proliferation and negatively influence patient survival. PLoS ONE 2013;8:e68744.
18. Zhang GJ, Zhou H, Xiao HX, et al. Up-regulation of miR-224 promotes cancer cell proliferation and invasion and predicts relapse of colorectal cancer. Cancer Cell Int 2013;13:104.
19. Liao WT, Li TT, Wang ZG, et al. microRNA-224 promotes cell proliferation and tumor growth in human colorectal cancer by repressing PHLPP1 and PHLPP2. Clin Cancer Res 2013;19:4662-72.
20. Yuan K, Xie K, Fox J, et al. Decreased levels of miR-224 and the passenger strand of miR-221 Increase MBD2, suppressing Maspin and promoting colorectal tumor growth and metastasis in mice. Gastroenterology 2013;145:853-64.e9.
21. Olaru AV, Yamanaka S, Vazquez C, et al. MicroRNA-224 negatively regulates p21 expression during late neoplastic progression in inflammatory bowel disease. Inflamm Bowel Dis 2013;19:471-80.
22. Salendo J, Spitzner M, Kramer F, et al. Identification of a microRNA expression signature for chemoradiosensitivity of colorectal cancer cells, involving miRNAs-320a, -224, -132 and let7g. Radiother Oncol 2013;108:451-7.
23. Mencia N, Selga E, Noe V, et al. Underexpression of miR-224 in methotrexate resistant human colon cancer cells. Biochem Pharmacol 2011;82:1572-82.
24. Hemminki A, Mecklin JP, Jarvinen H, et al. Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapy. Gastroenterology 2000;119:921-8.
25. Oberg AL, French AJ, Sarver AL, et al. miRNA expression in colon polyps provides evidence for a multihit model of colon cancer. PLoS ONE 2011;6:e20465.
26. Zhang B, Halder SK, Kashikar ND, et al. Antimetastatic role of Smad4 signaling in colorectal cancer. Gastroenterology 2010;138:969-80.e1-3.
27. Miyaki M, Iijima T, Konishi M, et al. Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis. Oncogene 1999;18:3098-103.
28. Xie W, Rimm DL, Lin Y, et al. Loss of Smad signaling in human colorectal cancer is associated with advanced disease and poor prognosis. Cancer J 2003;9:302-12.
29. Alazzouzi H, Alhopuro P, Salovaara R, et al. SMAD4 as a prognostic marker in colorectal cancer. Clin Cancer Res 2005;11:2606-11.
30. Yao G, Yin M, Lian J, et al. MicroRNA-224 is involved in transforming growth factor-beta-mediated mouse granulosa cell proliferation and granulosa cell function by targeting Smad4. Mol Endocrinol 2010;24:540-51.
31. Lichner Z, Mejia-Guerrero S, Ignacak M, et al. Pleiotropic action of renal cell carcinoma-dysregulated miRNAs on hypoxia-related signaling pathways. Am J Pathol 2012;180:1675-87.
32. Roth AD, Delorenzi M, Tejpar S, et al. Integrated analysis of molecular and clinical prognostic factors in stage II/III colon cancer. J Natl Cancer Inst 2012;104:1635-46.
33. Janssen HL, Reesink HW, Lawitz EJ, et al. Treatment of HCV infection by targeting microRNA. N Engl J Med 2013;368:1685-94.